Current funding
-
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis
NCI R01 Grant
PI Seongseok Yun MD PhD
6/1/2024-5/30/2029
-
Strategic therapeutic targeting to overcome Venetoclax resistance in acute myeloid leukemia
ASCO CDA Grant
PI Seongseok Yun MD PhD
7/1/2022-6/30/2025
-
Tumor suppressor roles of TFEB in the development and maintenance of myeloid leukemia
NCI K08 Grant
PI Seongseok Yun MD PhD
9/1/2019-8/31/2024
-
The role of MYC in age related myeloid neoplasms
Southeast Trust
PI Seongseok Yun MD PhD
1/1/2024-12/31/2024
-
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis
ASH Scholar Award
PI Nicole Vincelette PhD
7/1/2023-6/30/2025
-
The role of c-MYC and TFEB in the acute myeloid leukemia leukemogenesis
ASH Scholar Award
PI Seongseok Yun MD PhD
7/1/2019-4/30/2023
-
The roles of alarmins in cardiovascular disease associated with clonal hematopoiesis
Miles for Moffitt Pilot Grant
PI Seongseok Yun MD PhD
1/1/2023-12/31/2023